4
Changes in Ownership
REGENXBIO Inc. Filed Acc 0001562180-20-007351
President and CEO sold 15,000 shares at $45.00 ($675,000)
- President and CEO acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Mills Kenneth T. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-16 | Exercise or conversion : show line 1 in the form | +15,000 | $0.85 | $12,750 | 256,000 | D |
| 2020-12-16 | Sale : show line 2 in the form | −15,000 | $45.00 | $675,000 | 241,000 | D |
| Open-market sales · 15,000 sh · avg $45.00 · $675,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-16 | Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) | −15,000 | 60,170 | D |
Loading xslF345X03/primarydocument.xml…